| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of Prognostic Significance of Merkel Cell Polyomavirus in Chronic Lymphocytic Leukemia
|
Trizuljak, Jakub
|
|
2015
|
15 |
7 |
p. 439-442
4 p.
|
artikel
|
| 2 |
A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma
|
Cassaday, Ryan D.
|
|
2015
|
15 |
7 |
p. 392-397
6 p.
|
artikel
|
| 3 |
A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients
|
Cooper, Brenda W.
|
|
2015
|
15 |
7 |
p. 428-432.e2
42773 p.
|
artikel
|
| 4 |
Editorial Board/Masthead
|
|
|
2015
|
15 |
7 |
p. A2-
1 p.
|
artikel
|
| 5 |
Evaluation of Clinical and Biological Prognostic Factors in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients After Previous Treatment With Rituximab and Chemotherapy: Results of the PRO-R-IPI Study
|
Panizo, Carlos
|
|
2015
|
15 |
7 |
p. 398-403
6 p.
|
artikel
|
| 6 |
Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades
|
Bhatt, Vijaya Raj
|
|
2015
|
15 |
7 |
p. 409-415.e1
3742 p.
|
artikel
|
| 7 |
Oral Debio1143 (AT406), an Antagonist of Inhibitor of Apoptosis Proteins, Combined With Daunorubicin and Cytarabine in Patients With Poor-Risk Acute Myeloid Leukemia—Results of a Phase I Dose-Escalation Study
|
DiPersio, John F.
|
|
2015
|
15 |
7 |
p. 443-449
7 p.
|
artikel
|
| 8 |
Phase I Study of S-Trans, Trans-Farnesylthiosalicylic Acid (Salirasib), a Novel Oral RAS Inhibitor in Patients With Refractory Hematologic Malignancies
|
Badar, Talha
|
|
2015
|
15 |
7 |
p. 433-438.e2
43368 p.
|
artikel
|
| 9 |
Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma
|
Bila, Jelena
|
|
2015
|
15 |
7 |
p. 416-419
4 p.
|
artikel
|
| 10 |
Safety and Efficacy of Single-Agent Bendamustine After Failure of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin's Lymphoma: Experience With 27 Patients
|
Zinzani, Pier Luigi
|
|
2015
|
15 |
7 |
p. 404-408
5 p.
|
artikel
|
| 11 |
Second Cancers and Richter Transformation Are the Leading Causes of Death in Patients With Trisomy 12 Chronic Lymphocytic Leukemia
|
Strati, Paolo
|
|
2015
|
15 |
7 |
p. 420-427
8 p.
|
artikel
|
| 12 |
Table of Contents
|
|
|
2015
|
15 |
7 |
p. A12-A14
nvt p.
|
artikel
|
| 13 |
Three Newly Approved Drugs for Chronic Lymphocytic Leukemia: Incorporating Ibrutinib, Idelalisib, and Obinutuzumab into Clinical Practice
|
Sanford, David S.
|
|
2015
|
15 |
7 |
p. 385-391
7 p.
|
artikel
|
Tijdschrift beschrijving